Insulet is making significant strides in its key strategic imperatives to help patients manage diabetes efficiently. The ...

SAN DIEGO, September 10, 2024--DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, today announced the Dexcom G6 Continuous Glucose ...

While there is some optimism around Dexcom’s efforts to rebuild the Durable Medical Equipment (DME) channel and the filing of the 15-day G-Series sensor ... is a medical device manufacturing ...

Dexcom enjoys a well-established track record for introducing the most precise sensors for use in its continuous ... wave of innovation in the diabetes device market that has intensified ...

In this article, we will discuss the 10 best Internet of Things (IoT) stocks to buy. The Internet of Things (IoT) is a vast network connecting physical objects to the internet. Industries are ...

DexCom, Inc. (NASDAQ:DXCM) is a medical device company that develops and commercializes continuous glucose monitoring (CGM) systems. The one-month return of DexCom, Inc. (NASDAQ:DXCM) was 7.66% ...

Dexcom (DXCM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst William ...

The introduction of sensors like G6 and G7 in international markets also fueled revenue growth. Dexcom anticipates strong growth from its recent product launches and international expansions ...